Evidence map›Paper›PMID 35386048›Full record

ArticleNeurochemical research2022

Hyperammonemia Alters the Function of AMPA and NMDA Receptors in Hippocampus: Extracellular cGMP Reverses Some of These Alterations.

María Sancho-Alonso, Lucas Taoro-Gonzalez, Andrea Cabrera-Pastor, Vicente Felipo, Vicent Teruel-Martí

Abstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Hyperammonaemia disrupts daily rhythms reversibly by elevating glutamate in the central circadian pacemaker.Liver international : official journal of the International Association for the Study of the Liver · 2023
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

María Sancho-AlonsoLaboratory of Neurobiology, Centro de Investigación Príncipe Felipe, 46012, Valencia, Spain.
Lucas Taoro-GonzalezLaboratory of Neurobiology, Centro de Investigación Príncipe Felipe, 46012, Valencia, Spain.
Andrea Cabrera-PastorLaboratory of Neurobiology, Centro de Investigación Príncipe Felipe, 46012, Valencia, Spain.
Vicente FelipoLaboratory of Neurobiology, Centro de Investigación Príncipe Felipe, 46012, Valencia, Spain. vfelipo@cipf.es.ORCID http://orcid.org/0000-0003-3145-9538
Vicent Teruel-MartíAnatomy and Human Embryology Department, Faculty of Medicine, University of Valencia, 46010, Valencia, Spain.
Centro de Investigacion Principe Felipe · ESINCLIVA Health Research Institute · ESUniversitat de València · ES

Funding

Conselleria d'Educació, Investigació, Cultura i Esport ACIF/2018/291Conselleria d'Educació, Investigació, Cultura i Esport PROMETEOII/2018/051European Regional Development Funds PID2019-108562GB-I00European Regional Development Funds PID2020-113388RB-I00European Regional Development Funds PROMETEOII/2018/051European Regional Development Funds SAF2017-82917-RMinisterio de Ciencia, Innovación y Universidades PID2019-108562GB-I00Ministerio de Ciencia, Innovación y Universidades PID2020-113388RB-I00Ministerio de Ciencia, Innovación y Universidades SAF2017-82917-R
6 · The paper itself

Abstract

Chronic hyperammonemia alters membrane expression of AMPA and NMDA receptors subunits in hippocampus leading to impaired memory and learning. Increasing extracellular cGMP normalizes these alterations. However, it has not been studied whether hyperammonemia alters the function of AMPA and NMDA receptors. The aims of this work were: (1) assess if hyperammonemia alters AMPA and NMDA receptors function; (2) analyze if extracellular cGMP reverses these alterations. A multielectrode array device was used to stimulate Schäffer collaterals and record postsynaptic currents in the CA1 region in hippocampal slices from control and hyperammonemic rats and analyze different features of the excitatory postsynaptic potentials. Hyperammonemia reduces the amplitude and delays appearance of AMPA EPSPs, whereas increases amplitude, hyperpolarization, depolarization and desensitization area of the NMDA EPSPs. These alterations in AMPA and NMDA function are accentuated as the stimulation intensity increases. Adding extracellular cGMP reverses the alteration in amplitude in both, AMPA and NMDA EPSPs. In control slices extracellular cGMP decreases the AMPA and NMDA EPSPs amplitude and delays the response of neurons and the return to the resting potential at all stimulation intensities. In conclusion, hyperammonemia decreases the AMPA response, whereas increases the NMDA response and extracellular cGMP reverses these alterations.

Indexed as

HyperammonemiaReceptors, N-Methyl-D-Aspartatealpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic AcidAnimalsCyclic GMPHippocampusN-MethylaspartateRatsRats, WistarReceptors, AMPAalpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic AcidCyclic GMPN-MethylaspartateReceptors, AMPAReceptors, N-Methyl-D-AspartateAMPA receptorExcitatory postsynaptic evoked potentialsHippocampusHyperammonemiaMultielectrode arrayNMDA receptorSchäffer collaterals

Identifiers

PMID35386048
OpenAlexW4225912297

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.